Can bismuth subsalicylate (Pepto‑Bismol) be taken concomitantly with amoxicillin‑clavulanate (Clavulin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Use Pepto with Clavulin?

Yes, bismuth subsalicylate (Pepto-Bismol) can be safely taken with amoxicillin-clavulanate (Clavulin), and this combination is actually used therapeutically in certain infections, particularly for Helicobacter pylori eradication.

Evidence Supporting Concurrent Use

The combination of bismuth compounds with amoxicillin-containing regimens is well-established in clinical practice. Bismuth quadruple therapy explicitly combines bismuth subsalicylate with amoxicillin (as part of amoxicillin-clavulanate formulations) along with other antibiotics 1. The 2022 guidelines for H. pylori treatment recommend bismuth subsalicylate 2 tablets four times daily combined with antibiotics including amoxicillin-containing regimens 1.

Mechanism and Safety Profile

  • No pharmacokinetic interaction exists between bismuth subsalicylate and amoxicillin-clavulanate that would contraindicate their concurrent use
  • Bismuth works through multiple mechanisms including direct antimicrobial effects and disruption of bacterial iron homeostasis 2
  • The FDA drug label for Clavulin does not list bismuth as a contraindicated medication or significant drug interaction 3

Clinical Applications

Bismuth enhances antibiotic efficacy through several mechanisms:

  • Prevents development of antibiotic resistance when co-administered with antibiotics 4
  • Disrupts bacterial efflux pumps, allowing increased antibiotic accumulation inside bacteria 2
  • Provides additional antimicrobial activity against gastrointestinal pathogens 5, 6

Important Caveats

Timing Considerations

While concurrent use is safe, if you are taking these medications for H. pylori testing purposes, bismuth should be withheld for at least 4 weeks before urea breath testing or stool antigen testing to avoid false-negative results 7.

Salicylate Precautions

Since bismuth subsalicylate contains salicylate:

  • Avoid in children with viral infections (risk of Reye's syndrome) 8
  • Use caution if taking anticoagulants, as amoxicillin-clavulanate can prolong prothrombin time 3
  • Monitor for increased bleeding risk if on warfarin or other anticoagulants

Gastrointestinal Side Effects

Both medications can cause gastrointestinal symptoms:

  • Amoxicillin-clavulanate commonly causes diarrhea (2.9% in pediatric trials) 3
  • Bismuth subsalicylate is actually used to treat diarrhea and may help mitigate this side effect 6
  • The combination is generally well-tolerated when used as directed

Practical Recommendations

For concurrent use:

  • Take bismuth subsalicylate as directed (typically 2 tablets four times daily for therapeutic use)
  • Continue amoxicillin-clavulanate on its prescribed schedule
  • No special timing separation is required between doses
  • Complete the full course of antibiotics even if symptoms improve

This combination is not only safe but may actually enhance treatment efficacy for certain gastrointestinal infections through complementary mechanisms of action.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.